First patient treated with Leqembi® (lecanemab) in Sweden
Go back to First patient treated with Leqembi® (lecanemab) in Sweden| BARNES GROUP, Inc. (NYSE: B) | Delayed: 42.78 -1.1 (2.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $43.88 | 52 Week High | $44.27 | |||
| Open | $43.00 | 52 Week Low | $30.07 | |||
| Day High | $43.00 | P/E | 32.66 | |||
| Day Low | $42.13 | EPS | $1.31 | |||
| Volume | 5,526,862 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 7.79 -0.67 (7.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.46 | 52 Week High | $8.73 | |||
| Open | $8.43 | 52 Week Low | $2.86 | |||
| Day High | $8.49 | P/E | N/A | |||
| Day Low | $7.68 | EPS | $-3.82 | |||
| Volume | 266,038 | |||||
